Study to Determine Possible Effects of Apalutamide on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer |
Apalutamide, Biospecimen Collection, Questionnaire Administration, Transurethral Resection of Bladder Tumor |
Not yet recruiting |
Study of Kidney Tumors in Younger Patients |
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis |
Recruiting |
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Sargramostim |
Recruiting |
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer |
Dietary Intervention, Questionnaire Administration |
Active, not recruiting |
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis |
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Placebo Administration, Questionnaire Administration, Simvastatin |
Active, not recruiting |
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia |
Best Practice, Laboratory Biomarker Analysis, Supportive Care |
Active, not recruiting |
Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico |
Biopsy, Biospecimen Collection - Anal, Biospecimen Collection - Cervical, Colposcopy, High Resolution Anoscopy, Imaging Technique |
Recruiting |
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer |
Anxiety Questionnaire Administration, Quality-of-Life Assessment, Serum Tumor Marker directed disease monitoring, Usual care disease monitoring |
Recruiting |
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer |
Carvedilol, Laboratory Biomarker Analysis, Patient Observation |
Recruiting |
S0820, Adenoma and Second Primary Prevention Trial |
Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo |
Active, not recruiting |